IL-10 gene transfer attenuates P. gingivalis-induced inflammation

Journal of Dental Research

Volumn 86, Issue 6, 2007, Pages 560-564

  Houri Hoddod, Y ^a   Soskolne, W A ^a   Halabi, A ^a   Shapira, L ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Gene transfer; Inflammation; Porphyromonas gingivalis

Indexed keywords

AUTACOID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DIFFUSION CHAMBER; DOWN REGULATION; EXUDATE; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; PORPHYROMONAS GINGIVALIS; TIME;

ANIMALS; DIFFUSION CHAMBERS, CULTURE; DOWN-REGULATION; EXUDATES AND TRANSUDATES; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-1BETA; MICE; MICE, INBRED BALB C; PORPHYROMONAS GINGIVALIS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34347251184     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708600614     Document Type: Article

References (26)

1. Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN (2003). Accelerated alveolar bone loss in mice lacking interleukin 10. J Dent Res 82:632-635.
2. Apparailly F, Millet V, Noel D, Jacquet C, Sany J, Jorgensen C (2002). Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 13:1179-1188.
3. Asadullah K, Sterry W, Stephanek K, Jasulitis D, Leupold M, Audring H, et al. (1998). IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101:783-794.
4. Baker PJ, Evans RT, Roopenian DC (1994). Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch OralBiol 39:1035-1040.
5. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, et al. (1995). Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest 96:2339-2347.
6. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, et al. (1996). Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J Clin Invest 98:1010-1020.
7. Bogdan C, Vodovotz Y, Nathan C (1991). Macrophage deactivation by interleukin W.J Exp Med 174:1549-1555.
8. Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, et al. (1995). A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 154:5492-5499.
9. Cuzzocrea S, Mazzon E, Dugo L, Serranio I, Britti D, De Maio M, et al. (2001). Absence of endogenous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis. Eur Cytokine Netw 12:568-580.
10. Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT (1997). Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol 159:1945-1952.
11. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991). IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822.
12. Frolov I, Houri-Haddad Y, Soskolne A, Shapira L (1998). In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumor necrosis factor alpha production by cultured macrophages. Immunology 93:323-328.
13. Genco CA, Arko RJ (1994). Animal chamber models for study of hostparasite interactions. Methods Enzymol 235:120-140.
14. Houri-Haddad Y, Soskolne WA, Halabi A, Barak V, Shapira L (2000). Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferongamma response, and suppression of interleukin-10. Immunology 99:215-220.
15. Itoh K, Inoue T, Ito K, Hirohata S (1994). The interplay of interleukin10 (IL-10) and interleukin-2 (IL-2) in humoral immune responses: IL-10 synergizes with IL-2 to enhance responses of human B lymphocytes in a mechanism which is different from upregulation of CD25 expression. Cell Immunol 157:478-488.
16. Kesavalu L, Ebersole JL, Machen RL, Holt SC (1992). Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun 60:1455-1464.
17. Mosmann TR, Coffman RL (1989). Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
18. Owens JM, Gallagher AC, Chambers TJ (1996). IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol 157:936-940.
19. Pihlstrom BL, Michalowicz BS, Johnson NW (2005). Periodontal diseases. Lancet 366:1809-1820.
20. Puliti M, Von Hunolstein C, Verwaerde C, Bistoni F, Orefici G, Tissi L (2002). Regulatory role of interleukin-10 in experimental group B streptococcal arthritis. Infect Immun 70:2862-2868.
21. Ralph P, Nakoinz I, Sampson-Johannes A, Fong S, Lowe D, Min HY, et al. (1992). IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J Immunol 148:808814.
22. Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, Wollenberg GK, et al. (1995). Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 181:2289-2293.
23. Socransky SS, Haffajee AD (1992). The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol 63(4Suppl):322-331.
24. Taubman MA, Valverde P, Han X, Kawai T (2005). Immune response: the key to bone resorption in periodontal disease. J Periodontol 76(11Suppl):2033-2041.
25. Van Dyke TE, Lester MA, Shapira L (1993). The role of host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 64(8 Suppl):792-806.
26. Walmsley M, Katsikis PD, Abney E, Parry S, Williams RO, Maini RN, et al. (1996). Interleukin-10 inhibition of the progression of the established collagen-induced arthritis. Arthritis Rheum 39:495-503.